Fundraising Fox
Rational Vaccines
Universal City, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into Rational Vaccines
Each arrow is one introduction. Sign up to fill in the first one.
Ask Olivier Jarry to introduce you to Aziz Friedrich
You →Olivier · together at Rational Vaccines →Aziz
Sign up to find every way you can get introduced to Rational Vaccines
- Your email: who you already know at Rational Vaccines, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Rational Vaccines team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Rational Vaccines is an investigational-stage infectious disease company developing live attenuated viral immunotherapeutic and prophylactic vaccine candidates targeting herpes simplex virus 1 (HSV-1) and 2 (HSV-2) infections. It aims to treat, prevent, and diagnose herpes and herpes-related diseases, and is also applying its technology toward COVID-19.
Founders & leadership
Rational Vaccines was founded in 2015 by Agustin Fernandez III and William P. Halford.
Investors · 1
How we know: AAF Management Ltd.'s portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$27.8M disclosed across 5 rounds · 2015–2020
▶$11.7MraisedJun 2022 · 16 investors · BiotechnologyRule 506(b)
- Olivier JarryExecutive Officer
- Agustin FernandezExecutive Officer, Director
- David BrindleyExecutive Officer
- Jeffrey MaddenDirector
- Diane AbbittDirector
- Jason CammDirector
- Offering amount
- $11.7M
- Amount sold
- $11.7M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.8MraisedSep 2018 · 9 investors · PharmaceuticalsRule 506(b)
- Agustin Fernandez IIIExecutive Officer, Director
- Jason CammDirector
- Offering amount
- $30M
- Amount sold
- $6.8M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$8.2MraisedSep 2017 · 25 investors · PharmaceuticalsRule 506(b)
- Jason CammDirector
- Agustin Fernandez IIIExecutive Officer, Director
- Offering amount
- $8.2M
- Amount sold
- $8.2M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$364KraisedOct 2016 · 5 investors · PharmaceuticalsRule 506(b)
- William P. HalfordExecutive Officer, Director
- Agustin Fernandez IIIExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $364K
- First sale
- Oct 2016
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06b
▶$700KraisedSep 2015 · 10 investors · PharmaceuticalsRule 506(b)
- Paul BohmExecutive Officer
- Agustin Fernandez IIIExecutive Officer, Director
- Aziz FriedrichExecutive Officer
- William P. HalfordExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $700K
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Rational Vaccines.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $291.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $288.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $269.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Rational Vaccines do?
- Rational Vaccines is an investigational-stage infectious disease company developing live attenuated viral immunotherapeutic and prophylactic vaccine candidates targeting herpes simplex virus 1 (HSV-1) and 2 (HSV-2) infections. It aims to treat, prevent, and diagnose herpes and herpes-related diseases, and is also applying its technology toward COVID-19.
- Who founded Rational Vaccines?
- Rational Vaccines was founded by Agustin Fernandez III, William P. Halford in 2015.
- Who are Rational Vaccines's investors?
- Rational Vaccines's investors include AAF Management Ltd..
- How much funding has Rational Vaccines raised?
- Rational Vaccines has disclosed $27.8M raised across 5 rounds.
- Where is Rational Vaccines headquartered?
- Rational Vaccines is headquartered in Universal City, US.